文献速递心血管MR

新型冠状病毒肺炎康复者无临床心脏表现的细胞外容积分数升高与整体纵向应变减低

Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings.
PubMed 文献 · Radiology · 2021-01-12

前瞻性观察性队列研究纳入40例无心血管病史、无心脏症状、心电图及心肌酶正常的COVID-19康复者(中型肺炎24例、重型16例),出院超过90天行心脏MRI,与25名健康对照比较。康复者整体细胞外容积分数(ECV)升高、左室整体纵向应变减低,提示部分康复者存在亚临床心肌异常。

要点

  • COVID-19康复者无心脏症状且心电图、心肌酶正常时,心脏MRI仍可检出ECV升高和整体纵向应变减低。
  • 中型与重型肺炎康复者整体ECV中位数分别为29.7%和31.4%,均高于健康对照的25.0%(P均<.001)。
  • 康复者左室整体纵向应变为-12.5%,较健康对照的-15.4%减低(中型组P=.002,重型组P=.001)。

核心结论

  • 心脏MRI心肌组织及应变参数提示,部分COVID-19康复者在康复数月后可检出亚临床心肌异常。

研究设计与样本

  • 前瞻性观察性队列研究,纳入40例COVID-19康复者(中型肺炎24例、重型16例)及25名健康对照,于2020年5月至9月入组。

关键影像表现/征象

  • COVID-19康复者与健康对照之间左、右心室大小及功能无差异。
  • 仅1例(3%)康复者出现晚期钆增强阳性,位于下壁中段。
  • 康复者整体ECV升高,中型组中位数29.7%(四分位距28.0%-32.9%)、重型组31.4%(29.3%-34.0%),健康对照25.0%(23.7%-26.0%),P均<.001。
  • 康复者二维左室整体纵向应变减低,中型组-12.5%(四分位距-15.5%至-10.7%)、重型组-12.5%(-15.4%至-8.7%),健康对照-15.4%(-17.6%至-14.6%),P分别为.002和.001。

诊断标准与关键数值

  • 整体ECV中位数:中型肺炎康复组29.7% vs 重型肺炎康复组31.4% vs 健康对照组25.0%,两康复组均高于对照组(P均<.001)。
  • 二维左室整体纵向应变:中型组-12.5% vs 重型组-12.5% vs 健康对照组-15.4%,两康复组均较对照组减低(P=.002和P=.001)。

临床应用与阅片要点

  • 对无心脏症状、心电图及心肌酶正常的COVID-19康复者,心脏MRI组织特征(native T1、ECV)和应变成像可检出亚临床心肌异常。
  • 阅片时除常规心功能评估外,可关注ECV定量和整体纵向应变,即使晚期钆增强阴性也不能排除亚临床心肌受累。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background It is unknown if there are cardiac abnormalities in persons who have recovered from coronavirus disease 2019 (COVID-19) without cardiac symptoms or in those who have normal biomarkers and normal electrocardiograms. Purpose To evaluate cardiac involvement in participants who had recovered from COVID-19 without clinical evidence of cardiac involvement by using cardiac MRI. Materials and Methods This prospective observational cohort study included 40 participants who had recovered from COVID-19 with moderate (n = 24) or severe (n = 16) pneumonia and who had no cardiovascular medical history, were without cardiac symptoms, had normal electrocardiograms, had normal serologic cardiac enzyme levels, and had been discharged for more than 90 days between May and September 2020. Demographic characteristics were recorded, serum cardiac enzyme levels were measured, and cardiac MRI was performed. Cardiac function, native T1, extracellular volume fraction (ECV), and two-dimensional (2D) strain were quantitatively evaluated and compared with values in control subjects (n = 25). Comparisons among the three groups were performed by using one-way analysis of variance with Bonferroni-corrected post hoc comparisons (for normal distribution) or Kruskal-Wallis tests with post hoc pairwise comparisons (for nonnormal distribution). Results Forty participants (mean age, 54 years ± 12 [standard deviation]; 24 men) were enrolled; participants had a mean time between admission and cardiac MRI of 158 days ± 18 and between discharge and cardiac MRI examination of 124 days ± 17. There were no left or right ventricular size or functional differences between participants who had recovered from COVID-19 and healthy control subjects. Only one (3%) participant had positive late gadolinium enhancement located at the mid inferior wall. Global ECV values were elevated in participants who had recovered from COVID-19 with moderate or severe pneumonia compared with those in healthy control subjects (median ECV, 29.7% vs 31.4% vs 25.0%, respectively; interquartile range, 28.0%-32.9% vs 29.3%-34.0% vs 23.7%-26.0%, respectively; P < .001 for both). The 2D global left ventricular longitudinal strain was reduced in both groups of participants (moderate COVID-19 group, -12.5% [interquartile range, -15.5% to -10.7%]; severe COVID-19 group, -12.5% [interquartile range, -15.4% to -8.7%]) compared with the healthy control group (-15.4% [interquartile range, -17.6% to -14.6%]) (P = .002 and P = .001, respectively). Conclusion Cardiac MRI myocardial tissue and strain imaging parameters suggest that a proportion of participants who had recovered from COVID-19 had subclinical myocardial abnormalities detectable months after recovery. © RSNA, 2021 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Li X, Wang H, Zhao R, et al. Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings. Radiology. 2021. PMID: 33434112. doi:10.1148/radiol.2021203998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。